Get your Emails warmed up and ready to send

Build sender reputation and reach more inboxes with automated email warmup.

Warm up your emails

Starting at $49/month

Start Warming Up

Randy Taylor

Rare Disease Oncology Account Manager @Syndax Pharmaceuticals

Phoenix, AZ, US
EMAILS
r••••••@syndax.com
MOBILE NUMBERS
+16•••••••69

Signup · Get unlimited contacts

WORK HISTORY

Sep 2025 — Present

Rare Disease Oncology Account Manager @Syndax Pharmaceuticals

AZ and NM Accounts• Leads market development for Revuforj (rare AML & ALL) and Niktimvo (chronic GVHD) across academic and community oncology networks• Builds early market adoption strategies within a startup rare disease oncology environment, partnering with hematology leaders and multidisciplinary care teams• Develops key account access, referral mapping, and patient identification programs to accelerate treatment starts

EDUCATION

N/A

W. P. Carey School of Business – Arizona State University

Bachelor of Science - BS, Business Administration and Management, General

SKILLS

Cns DisordersMonoclonal AntibodiesDermatologyImmunologyPharmaceutical IndustryBiotechnologyInfectious DiseasesPulmonologyOncologyRheumatologyProduct LaunchGastroenterologyPharmaceutical SalesMedical BillingHematologyManaged CarePharmaceuticsAllergy

ABOUT RANDY TAYLOR

Proven commercial leader with a successful track record in three biotech startups, delivering rapid market growth in both oncology and rare disease settings. Over eight years in oncology and five years in rare disease, built, launched, and expanded brands that change the treatment landscape for complex, underserved patient populations. Combines scientific depth with commercial precision, equally skilled in launching breakthrough therapies, navigating complex market-access ecosystems, and building trusted relationships with key opinion leaders, C-suite stakeholders, and integrated delivery networks. Known for leading high-impact launches (Revuforj, Niktimvo, Darzalex, Imbruvica, Zofran, Lupkynis, Remicade), driving category growth in competitive markets, and cultivating rare-disease commercialization excellence within startup and large-cap biotech environments.C-Suite Rapport, Contract Negotiation and Management, Buy-and-Bill Management, Rare Disease, KOL Relations and Development, Business / Risk Analytics, Gains Stakeholder Commitment, Overcomes Resistance, Diversity Awareness and Sensitivity, Strong Emotional Intelligence, Interpersonal Skills, Persistence and Loyalty, Sales Training, CPT-4 and J-Coding

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.